Apogee Therapeutics, Inc. Current Income Tax Expense (Benefit)
Apogee Therapeutics, Inc. (APGE) reported Current Income Tax Expense (Benefit) of $278.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-02
- Apogee Therapeutics, Inc. current income tax expense (benefit) for fiscal 2025 was $278.00K, a 1444.44% increase from fiscal 2024.
- Apogee Therapeutics, Inc. current income tax expense (benefit) for fiscal 2024 was $18.00K.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $278.00K 10-K · filed 2026-03-02 |
| 2024-12-31 | $18.00K 10-K · filed 2026-03-02 |